"Every time it comes up in the news we get a spike in patients asking about it and every time we have to say 'Im sorry we cant prescribe that at the moment'
It also slows down digestion, preventing sharp glucose spikes after meals
Appetite Suppression: The medication targets the hunger centers in the brain, significantly reducing cravings and the desire to eat
The percentage change in total fat mass and lean mass, measured by DXA, reached 33.9% and 10.9% with tirzepatide, respectively, compared to 8.2% and 2.6% with placebo [33] (Table 1)
Obesity works exactly the same wayits a chronic medical condition that usually needs ongoing care
GLP-1 receptor agonist preserves calorie burn while melting fat, proven by a 10.2% average weight loss sustained for 4 years